Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein.

The polyglutamine diseases are a family of nine proteins where intracellular protein misfolding and amyloid-like fibril formation are intrinsically coupled to disease. Previously, we identified a complex two-step mechanism of fibril formation of pathologically expanded ataxin-3, the causative protein of spinocerebellar ataxia type-3 (Machado-Joseph disease). Strikingly, ataxin-3 lacking a polyglutamine tract also formed fibrils, although this occurred only via a single-step that was homologous to the first step of expanded ataxin-3 fibril formation. Here, we present the first kinetic analysis of a disease-associated polyglutamine repeat protein. We show that ataxin-3 forms amyloid-like fibrils by a nucleation-dependent polymerization mechanism. We kinetically model the nucleating event in ataxin-3 fibrillogenesis to the formation of a monomeric thermodynamic nucleus. Fibril elongation then proceeds by a mechanism of monomer addition. The presence of an expanded polyglutamine tract leads subsequently to rapid inter-fibril association and formation of large, highly stable amyloid-like fibrils. These results enhance our general understanding of polyglutamine fibrillogenesis and highlights the role of non-poly(Q) domains in modulating the kinetics of misfolding in this family.

[1]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Stephen P Bottomley,et al.  The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step* , 2006, Journal of Biological Chemistry.

[3]  F. Heitz,et al.  Structural Instability and Fibrillar Aggregation of Non-expanded Human Ataxin-3 Revealed under High Pressure and Temperature* , 2003, Journal of Biological Chemistry.

[4]  F. Hartl,et al.  Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. , 2006, Human molecular genetics.

[5]  J R Ghilardi,et al.  Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. , 2000, Biochemistry.

[6]  K. Fischbeck,et al.  Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain , 1997, Annals of neurology.

[7]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[8]  A. Pastore,et al.  Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. , 2005, Journal of molecular biology.

[9]  Stephen P Bottomley,et al.  Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. , 2004, Journal of molecular biology.

[10]  Adam Douglass,et al.  Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.

[11]  Fumiaki Tanaka,et al.  Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. , 2003, Human molecular genetics.

[12]  S. Brahmachari,et al.  Identification of a novel 45 repeat unstable allele associated with a disease phenotype at the MJD1/SCA3 locus , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  K. Lindenberg,et al.  Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions , 2002, Annals of neurology.

[14]  Annalisa Pastore,et al.  Domain architecture of the polyglutamine protein ataxin‐3: a globular domain followed by a flexible tail , 2003, FEBS letters.

[15]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[16]  P. Loll,et al.  An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel β-fibrils , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Kelly,et al.  Influence of the N‐terminal domain on the aggregation properties of the prion protein , 2005, Protein science : a publication of the Protein Society.

[18]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[19]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[20]  R. Wetzel,et al.  A microtiter plate assay for polyglutamine aggregate extension. , 2001, Analytical biochemistry.

[21]  H. Paulson,et al.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.

[22]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Lehrach,et al.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. , 1999, Methods in enzymology.

[24]  Sandra Macedo-Ribeiro,et al.  Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. , 2005, Journal of molecular biology.

[25]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[26]  Lisa D. Cabrita,et al.  Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein Stability , 2004, Journal of Biological Chemistry.

[27]  S. Tsuji,et al.  Expanded polyglutamine stretches form an ‘aggresome’ , 2002, Neuroscience Letters.

[28]  Ronald Wetzel,et al.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[30]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[31]  N. Weigel,et al.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.

[32]  Giuseppe Nicastro,et al.  Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. , 2004, Journal of molecular biology.

[33]  S. Bottomley,et al.  The Role of Protein Misfolding in the Pathogenesis of Human Diseases , 2004, IUBMB life.

[34]  Lisa D. Cabrita,et al.  A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production , 2006, BMC biotechnology.

[35]  K. Fischbeck,et al.  Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3 , 1997, Neuron.

[36]  Ronald Wetzel,et al.  Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K Dane Wittrup,et al.  Stochastic kinetics of intracellular huntingtin aggregate formation , 2006, Nature chemical biology.

[38]  K. Hofmann,et al.  Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. , 2003, Human molecular genetics.

[39]  P. Tortora,et al.  Temperature-dependent, irreversible formation of amyloid fibrils by a soluble human ataxin-3 carrying a moderately expanded polyglutamine stretch (Q36). , 2003, Biochemistry.

[40]  A Dürr,et al.  Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. , 1998, Human molecular genetics.

[41]  J. Walcott,et al.  Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. , 2001, Human molecular genetics.

[42]  Michelle K. M. Chow,et al.  Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. , 2004, Biochemical and biophysical research communications.

[43]  Zoya Ignatova,et al.  Extended Polyglutamine Tracts Cause Aggregation and Structural Perturbation of an Adjacent β Barrel Protein* , 2006, Journal of Biological Chemistry.

[44]  P. Schuck,et al.  Determination of the sedimentation coefficient distribution by least-squares boundary modeling. , 2000, Biopolymers.

[45]  A. Pastore,et al.  Expansion of amino acid homo-sequences in proteins: Insights into the role of amino acid homo-polymers and of the protein context in aggregation , 2006, Cellular and Molecular Life Sciences CMLS.

[46]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.